The Cannabist Company Holdings Inc. Announces Co-Founder Michael Abbott's Resignation from Board

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) has announced the resignation of Michael Abbott, co-founder and member of the Board of Directors, effective October 3, 2025. Abbott, instrumental in the establishment of the Company originally as Columbia Care in 2012, has led various leadership roles, including Executive Chairman of the Board until 2023 and subsequently as Chair of the Board. His decision to step down comes as he looks to pursue new personal and professional commitments. David Hart, CEO and Director of The Cannabist Company, expressed gratitude for Abbott's significant contributions and support over the years, wishing him success in his future endeavors.

The Cannabist Company, known for its dedicated cultivation, manufacturing, and retailing of cannabis products, operates across 12 U.S. jurisdictions, managing 77 facilities that include 61 dispensaries and 16 cultivation and manufacturing sites. As a pioneer in the multi-state cannabis sector, the Company continues to serve both medical and adult-use markets with its wide range of products, which include flower, edibles, oils, and tablets. In 2021, the launch of the Cannabist retail brand helped solidify its presence in the national dispensary network, utilizing proprietary technology to enhance consumer experience.

The Cannabist Company aims to maintain its leadership in the industry by offering popular brands like dreamt, Seed & Strain, Triple Seven, and more. With Abbott's departure marking the end of an era for the Company, stakeholders and investors will be keenly observing how the Board and management team navigate this transition and continue to drive growth and innovation in the rapidly evolving cannabis landscape.

For additional details, visit www.cannabistcompany.com.

The recent announcement of Michael Abbott's resignation from The Cannabist Company's Board of Directors may raise eyebrows among investors. As co-founder and former Executive Chairman, Abbott has played a pivotal role in shaping the company since its inception as Columbia Care in 2012. His departure, while understandable due to personal and professional commitments, could have implications for stakeholder confidence and the firm's strategic direction.

The Cannabist Company stands as a prominent player in the cannabis industry, operating across 12 states with 77 facilities, including 61 dispensaries. The company's extensive portfolio of products and brands underlines its market presence and ability to serve both medical and recreational cannabis needs. However, Abbott's resignation could hint at potential transitional challenges, particularly in leadership continuity and governance, which investors should monitor closely.

Despite this development, it's essential to recognize the robust operational foundation and growth trajectory of The Cannabist Company. The establishment of the Cannabist retail brand has been a strategic move, positioning the company favorably within an increasingly competitive landscape. As the legalization of cannabis broadens and consumer acceptance grows, the company is well-poised to capitalize on market opportunities.

Investors may consider maintaining a cautious yet optimistic outlook. The leadership gap created by Abbott’s exit presents an opportunity for new perspectives and strategies; however, it’s crucial to ensure that the transition does not disrupt the company’s momentum. Keeping an eye on how the Board fills Abbott's position and any new strategic initiatives that emerge will be key.

In summary, while Abbott's resignation poses some uncertainty, The Cannabist Company's solid market position and diversified product offerings continue to offer potential for growth. Stakeholders should remain attentive to further leadership developments as the company navigates this transition.